A randomized, split-face, comparative clinical study on the efficacy of Eucerin ultraWHITE+ spotless and the combination of 2%hydroquinone and 4%arbutin for the treatment of skin hyperpigmentatio
Phase 2
Completed
- Conditions
- epidermal melasma
- Registration Number
- TCTR20190614008
- Lead Sponsor
- Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
participants with epidermal melasma
Exclusion Criteria
-subjects who receive any topical treatment within 2 weeks or laser treatment within 3 months
-pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skin lightness (L) week 0,4,8,12 multi-probe adapter system Cutometer dual MPA580
- Secondary Outcome Measures
Name Time Method clinical grading week 0,4,8,12 photograph